Correlation Between Raphael Pharmaceutical and Regencell Bioscience

Can any of the company-specific risk be diversified away by investing in both Raphael Pharmaceutical and Regencell Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Raphael Pharmaceutical and Regencell Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Raphael Pharmaceutical and Regencell Bioscience Holdings, you can compare the effects of market volatilities on Raphael Pharmaceutical and Regencell Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Raphael Pharmaceutical with a short position of Regencell Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Raphael Pharmaceutical and Regencell Bioscience.

Diversification Opportunities for Raphael Pharmaceutical and Regencell Bioscience

0.15

Correlation Coefficient

Raphael Pharmaceutical  Regencell Bioscience

Average diversification

The 3 months correlation between Raphael and Regencell is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Raphael Pharmaceutical and Regencell Bioscience Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regencell Bioscience and Raphael Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Raphael Pharmaceutical are associated (or correlated) with Regencell Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regencell Bioscience has no effect on the direction of Raphael Pharmaceutical i.e., Raphael Pharmaceutical and Regencell Bioscience go up and down completely randomly.

Pair Corralation between Raphael Pharmaceutical and Regencell Bioscience

Given the investment horizon of 90 days Raphael Pharmaceutical is expected to generate 2.03 times less return on investment than Regencell Bioscience. But when comparing it to its historical volatility, Raphael Pharmaceutical is 2.51 times less risky than Regencell Bioscience. It trades about 0.2 of its potential returns per unit of risk. Regencell Bioscience Holdings is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  482.00  in Regencell Bioscience Holdings on December 29, 2024 and sell it today you would earn a total of  2,085  from holding Regencell Bioscience Holdings or generate 432.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.31%
Values	Daily Returns

Raphael Pharmaceutical  vs.  Regencell Bioscience Holdings

Raphael Pharmaceutical

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Raphael Pharmaceutical are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, Raphael Pharmaceutical demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Regencell Bioscience

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Regencell Bioscience Holdings are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile technical and fundamental indicators, Regencell Bioscience exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Raphael Pharmaceutical and Regencell Bioscience

The main advantage of trading using opposite Raphael Pharmaceutical and Regencell Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Raphael Pharmaceutical position performs unexpectedly, Regencell Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regencell Bioscience will offset losses from the drop in Regencell Bioscience's long position.

The idea behind Raphael Pharmaceutical and Regencell Bioscience Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.